Hepatitis B virus (HBV) is a hepatotropic virus and an important human pathogen. There are
an estimated 296 million people in the world that are chronically infected by this virus, and …

Hepatitis B virus (HBV) affects approximately two billion people worldwide and more than
240 million people in the world are currently chronic carrier that could develop serious …

Background & Aims Current therapy for chronic hepatitis B virus (cHBV) infection involves
lifelong treatment. New treatments that enable HBV functional cure would represent a …

Epidemiology: incidence and prevalence: About 5% of the world's population has chronic
hepatitis B virus (HBV) infection, and nearly 25% of carriers develop chronic hepatitis …

Liver diseases represent a major global health burden accounting for approximately 2
million deaths per year worldwide. The liver functions as a primary immune organ that is …

Hepatitis B virus infection affects over 250 million chronic carriers, causing more than
800,000 deaths annually, although a safe and effective vaccine is available. Currently used …

Chronic hepatitis B virus (HBV) infection is one of the major global health problems.
Although the small protein of hepatitis B virus surface antigen (HBsAg), SHBs, is the most …

Hepatocellular carcinoma (HCC) is a hypervascular tumor, and accumulating evidence has
indicated that stimulation of angiogenesis by hepatitis B virus (HBV) may contribute to HCC …

Hepatitis B Virus (HBV) is a significant public health challenge. Around 250 million people
live with chronic HBV infection. With a global approach to this issue, we focus on new …

Hepatitis B virus (HBV) infection is a major global health problem of widespread concern.
Clinically, serological assays are the most widely used diagnostic tests for HBV infection …